Markus Pompejus, VP at BASF, to Keynote at Biobased Chemicals Conf. (Sep 18-19, 2014 San Francisco)
San Francisco, CA, June 13, 2014 --(PR.com
)-- Markus Pompejus, Vice President of White Biotechnology Research at BASF will give a keynote presentation at the 5th Biobased Chemicals Commercialization & Partnering Conference to be held on Sep. 18-19, 2014 in San Francisco, CA.
As Vice President, Dr. Markus Pompejus heads research for White Biotechnology for BASF in North America. Dr. Pompejus has various responsibilities and leadership roles in BASF in Germany, South Korea and the U.S., ranging from research, product and process development, commercial operations and production to new business development. He has strong experience in the areas of genetic and metabolic engineering, bioprocessing, bioactive materials, scale-up and production. Starting June 2011, he began heading the Research for Bioactive Materials and White Biotechnology Research for BASF Corporation in Tarrytown, NY. Starting with the acquisition of Verenium in November 2013, Dr. Pompejus assumed his current position with locations in Tarrytown, NY and San Diego, CA.
This two-day conference brings together top representatives who are engaged in establishing a major transformation in the global chemical and energy industries from petroleum to biobased. The conference will look to examine new supply chain developments and business models being adopted for biobased chemicals products. Topics covered include novel chemical production platforms, advantageous feedstock, securing funding and strategic partnerships, trends and challenges in commercial scale up, end user applications, and consumer products. Renewable chemical companies, biofuel companies and end market consumers will be discussing innovations in the science, technology and end-market development of biobased chemicals, polymers and plastics.
Sessions for 2014 Agenda:
I. Novel Technologies & Platforms in Biochemical Production
II. Advantageous Feedstock for Biochemical Commercialization
III. Trends & Challenges in Commercial Scale Up
IV. Panel Discussion: Funding Opportunities
V. Strategic Partnerships
VI. Panel Discussion: Strategic Partnerships
VII. Panel Discussion: The Role of Government in Commercializing Biochemicals
VIII. End User Applications & Consumer Products
For more information, please visit www.gtcbio.com/biobasedchemicals